Incyte Corporation

673 articles about Incyte Corporation

• Incyte Corporation Begins Phase I Study Of INCB13739 As A New Treatment For Type 2 Diabetes

  6/7/2006

• Incyte Corporation Begins Phase I Study Of New HIV Drug In Healthy Volunteers

  5/10/2006

• Incyte Corporation Announces First Quarter Financial Results And Provides Update On Drug Discovery And Development Programs

  5/4/2006

• Incyte Corporation Invites Investors To Listen To Webcast Of Presentation At The Morgan Stanley Global Healthcare Unplugged Conference

  4/25/2006

• Incyte Corporation To Report First Quarter 2006 Financial Results

  4/21/2006

• Incyte Corporation To Discontinue Development Of DFC As A Treatment For HIV

  4/3/2006

• Incyte Corporation Announces 2005 Financial Results And Provides 2006 Guidance

  2/16/2006

• Incyte Corporation To Report 2005 Financial Results And 2006 Financial Guidance

  1/26/2006

• Incyte Corporation To Present At The 24th Annual JPMorgan Healthcare Conference

  1/5/2006

• Pfizer Inc. To Buy Incyte Corporation Drugs For Up To $803 Million

  11/21/2005

• The Day In Review: Biotech Backs Off A Little

  7/25/2005

• Incyte Corporation To Present At The 23rd Annual JPMorgan Healthcare Conference

  1/7/2005

• Genzyme Beats Expectations, Jumps 12%

  7/15/2004